LABP logo

Landos Biopharma (LABP) Free Cash Flow

Annual FCF

-$20.48 M
+$25.30 M+55.27%

December 31, 2023


Summary


Performance

LABP Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherLABPcash flowmetrics:

Quarterly FCF

-$8.50 M
-$3.53 M-71.02%

March 31, 2024


Summary


Performance

LABP Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherLABPcash flowmetrics:

TTM FCF

-$20.80 M
-$328.00 K-1.60%

March 31, 2024


Summary


Performance

LABP TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherLABPcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

LABP Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+55.3%-281.4%-8.3%
3 y3 years+11.5%+32.7%+35.8%
5 y5 years-195.1%--

LABP Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+123.6%+281.4%+111.8%+8.3%+181.8%
5 y5-year+104.1%+123.6%-191.9%+111.8%+514.1%+181.8%
alltimeall time+195.1%+123.6%-191.9%+111.8%+514.1%+181.8%

Landos Biopharma Free Cash Flow History

DateAnnualQuarterlyTTM
Mar 2024
-
-$8.50 M(+71.0%)
-$20.80 M(+1.6%)
Dec 2023
-$20.48 M(-55.3%)
-$4.97 M(+123.0%)
-$20.48 M(+6.6%)
Sep 2023
-
-$2.23 M(-56.4%)
-$19.21 M(-21.8%)
Jun 2023
-
-$5.11 M(-37.5%)
-$24.55 M(-34.4%)
Mar 2023
-
-$8.17 M(+120.9%)
-$37.44 M(-18.2%)
Dec 2022
-$45.78 M(+66.5%)
-$3.70 M(-51.2%)
-$45.78 M(-15.4%)
Sep 2022
-
-$7.57 M(-57.9%)
-$54.10 M(-7.7%)
Jun 2022
-
-$18.00 M(+9.0%)
-$58.63 M(+86.8%)
Mar 2022
-
-$16.51 M(+37.3%)
-$31.39 M(+14.1%)
DateAnnualQuarterlyTTM
Dec 2021
-$27.50 M(+18.8%)
-$12.02 M(-0.7%)
-$27.50 M(+14.8%)
Sep 2021
-
-$12.11 M(-230.9%)
-$23.96 M(+39.0%)
Jun 2021
-
$9.25 M(-173.3%)
-$17.25 M(-46.7%)
Mar 2021
-
-$12.62 M(+48.9%)
-$32.38 M(+39.9%)
Dec 2020
-$23.14 M(+130.7%)
-$8.48 M(+57.3%)
-$23.14 M(+57.8%)
Sep 2020
-
-$5.39 M(-8.4%)
-$14.66 M(+58.1%)
Jun 2020
-
-$5.88 M(+73.6%)
-$9.27 M(+173.6%)
Mar 2020
-
-$3.39 M
-$3.39 M
Dec 2019
-$10.03 M(+44.6%)
-
-
Dec 2018
-$6.94 M
-
-

FAQ

  • What is Landos Biopharma annual free cash flow?
  • What is the all time high annual FCF for Landos Biopharma?
  • What is Landos Biopharma annual FCF year-on-year change?
  • What is Landos Biopharma quarterly free cash flow?
  • What is the all time high quarterly FCF for Landos Biopharma?
  • What is Landos Biopharma quarterly FCF year-on-year change?
  • What is Landos Biopharma TTM free cash flow?
  • What is the all time high TTM FCF for Landos Biopharma?
  • What is Landos Biopharma TTM FCF year-on-year change?

What is Landos Biopharma annual free cash flow?

The current annual FCF of LABP is -$20.48 M

What is the all time high annual FCF for Landos Biopharma?

Landos Biopharma all-time high annual free cash flow is -$6.94 M

What is Landos Biopharma annual FCF year-on-year change?

Over the past year, LABP annual free cash flow has changed by +$25.30 M (+55.27%)

What is Landos Biopharma quarterly free cash flow?

The current quarterly FCF of LABP is -$8.50 M

What is the all time high quarterly FCF for Landos Biopharma?

Landos Biopharma all-time high quarterly free cash flow is $9.25 M

What is Landos Biopharma quarterly FCF year-on-year change?

Over the past year, LABP quarterly free cash flow has changed by -$6.27 M (-281.42%)

What is Landos Biopharma TTM free cash flow?

The current TTM FCF of LABP is -$20.80 M

What is the all time high TTM FCF for Landos Biopharma?

Landos Biopharma all-time high TTM free cash flow is -$3.39 M

What is Landos Biopharma TTM FCF year-on-year change?

Over the past year, LABP TTM free cash flow has changed by -$1.60 M (-8.32%)